Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty
Joint Authors
Atay, Memiş Hilmi
Yaylali, Yalin Tolga
Özdemir, Mahmut
Yurtdaş, Mustafa
Aladağ, Nesim
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-03-10
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%.
We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
American Psychological Association (APA)
Yurtdaş, Mustafa& Yaylali, Yalin Tolga& Aladağ, Nesim& Özdemir, Mahmut& Atay, Memiş Hilmi. 2014. Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty. Case Reports in Medicine،Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-453127
Modern Language Association (MLA)
Yurtdaş, Mustafa…[et al.]. Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty. Case Reports in Medicine No. 2014 (2014), pp.1-3.
https://search.emarefa.net/detail/BIM-453127
American Medical Association (AMA)
Yurtdaş, Mustafa& Yaylali, Yalin Tolga& Aladağ, Nesim& Özdemir, Mahmut& Atay, Memiş Hilmi. Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty. Case Reports in Medicine. 2014. Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-453127
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-453127
